← Open Payments lookup

MELISSA FLEMISTER: Open Payments

NPI 1205275120 · MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$738 in 25 payments from 13 companies in 2025. Trend: 2023 $653 · 2024 $602 · 2025 $738

Food & beverage: $738
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP3$215
Novo Nordisk Inc5$169
PFIZER INC.4$92
GlaxoSmithKline, LLC.3$63
Lilly USA, LLC2$35
UCB, Inc.1$31
ABBVIE INC.1$24
Neurelis, Inc.1$23
Axsome Therapeutics, Inc.1$20
Boehringer Ingelheim Pharmaceuticals, Inc.1$19

Products named: FARXIGA, Ozempic, PREVNAR 20, Rybelsus, JARDIANCE, Briviact, AIRSUPRA, VRAYLAR.

Industry payments across LA — which companies pay providers there.